BEDFORD, Mass., Nov. 25 /PRNewswire-FirstCall/ -- Hologic, Inc. , a leading provider of specialized medical imaging equipment for women's health, today announced the signing of a sales agreement with Mammography Reporting Systems, Inc. Headquartered in Seattle, Washington, Mammography Reporting System, Inc. (MRS) is a leading provider of computerized systems for collecting, reporting, tracking and analyzing breast-imaging information. Under the terms of the agreement, Hologic and MRS will work cooperatively to offer the MRS portfolio of products to healthcare facilities currently using or purchasing Hologic's line of screen-film and digital mammography systems.
The MRS Mammography Reporting System is a cost-effective tool for improving operational efficiency and allowing facilities that perform mammography and other breast-related procedures to meet the requirements of the Mammography Quality Standards Act (MQSA). The system generates radiologist exam reports and automatically selects lay-language patient result letters. It also tracks problem cases, generates follow-up letters and provides medical audit and practice management statistical reports. MRS systems are adaptable to a variety of mammography environments and workflow processes.
"The powerful tracking and reporting systems from MRS have a proven track record of increasing efficiencies for mammography professionals and aiding in the delivery of the highest quality care," said Jack Cumming, Hologic's Chairman and CEO. "Enhanced workflow has become increasingly important to busy facilities facing cost constraints due to reimbursement inadequacies. The MRS technology ideally complements Hologic's mammography and image management solutions. Our ability to offer these products should have a positive impact on the early and more efficient detection of breast cancer. We are very pleased to have the opportunity to work with MRS in this endeavor."
Hologic's product offerings include the Lorad Selenia(TM), the industry's first full-field digital mammography system using direct capture technology, the M-IV and Affinity Series of screen-film mammography systems, and a customized ultrasound system optimized for women's imaging and manufactured by Aloka Company, Ltd. The company also provides both upright and prone stereotactic breast biopsy systems. In addition, recent distribution agreements with R2 Technology and Confirma allow Hologic to offer a range of Computer Aided Detection (CAD) product offerings. Hologic and MRS have also worked together in the past to customize MRS software interfaces to provide seamless functionality with the Lorad Selenia system.
"MRS currently supports more than 2,000 facilities worldwide and is committed to providing high quality, state-of-the-art computerized systems for the healthcare industry," commented Stan Sieberg, President of Mammography Reporting System, Inc. "Our partnership with Hologic will facilitate access to their customer base and enable hospitals and clinics to improve their breast cancer detection by enhancing the workflow process."
Hologic, Inc. is a leading developer, manufacturer and supplier of medical imaging systems dedicated to serving the healthcare needs of women, and a leading developer of state-of-the-art digital imaging technology for general radiography and mammography applications. Hologic's core business units are focused on osteoporosis assessment, mammography and breast biopsy, direct-to- digital X-ray for general radiography applications and mini C-arm imaging for orthopedic applications. For more information, please visit http://www.hologic.com/.
About Mammography Reporting Systems, Inc.
Mammography Reporting Systems, Inc., headquartered in Seattle, Washington, is a leading provider of mammography information systems in the United States. MRS is dedicated to producing the premier reporting systems in the industry with features such as the new SQL product for multi-facility enterprises with One-touch(TM) reporting, Print-to-Mail(TM) capability, and e-mail capability as well as the HL7 RIS/HIS, DICOM, film flasher and voice recognition interfaces. MRS systems aid in the reduction of operating costs, administrative hassles and legal exposure, while providing the administrative support necessary for facilities to meet Mammography Quality Standards Act (MQSA) requirements. For more information, visit http://www.mrsys.com/ on the Internet. For media information contact Stan Sieberg, MRS Inc., 206.633.6145 Ext. 3039, or firstname.lastname@example.org. MRS Mammography Reporting System is a registered trademark of Mammography Reporting System Inc.
Forward Looking Statement
This News Release contains forward-looking information that involves risks and uncertainties, including statements about Hologic's plans, objectives, expectations and intentions. Such statements include, without limitation, statements regarding the relationship and anticipated benefits from Hologic's agreement with Mammography Reporting System, Inc. These forward-looking statements are subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those anticipated. Factors that could cause actual results to materially differ include, without limitation; Hologic's ability to predict accurately the demand for its products and to develop strategies to address its markets successfully; uncertainties inherent in the development of new products and the enhancement of existing products, including technical and regulatory risks, such as the ability to obtain FDA approval to market products developed, cost overruns and delays; the risk that newly introduced products may contain undetected errors or defects or otherwise not perform as anticipated; the early stage of market development for digital X-ray products; risks relating to Hologic's reliance on a single source of supply for some key components of its products; the need to comply with especially high standards in the manufacture of digital X-ray products; Hologic's ongoing ability to satisfy financial and other covenants in its credit and lease agreements; technical innovations that could render products marketed or under development by Hologic obsolete; competition; and reimbursement policies for the use of Hologic's products. Other factors that could adversely affect Hologic's business and prospects are described in Hologic's filings with the Securities and Exchange Commission. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Hologic's expectations or any change in events, conditions or circumstances on which any such statement is based.
Contact: Glenn P. Muir Frances Crecco
Executive Vice President and CFO Manager, Investor Relations
Hologic, Inc. Hologic, Inc.
(781) 999-7300 (781) 999-7377